Guardant Health, Inc.
GHNasdaqCIK 1576280HealthcareFiscal year ends Dec 31
Reports and events: 150 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-07-3020:46 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001576280-26-000037 |
| 2026-07-3020:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-26-000036 |
| 2026-06-1820:11 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-275864 |
| 2026-05-0721:16 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001576280-26-000026 |
| 2026-05-0720:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-26-000024 |
| 2026-04-2820:46 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001193125-26-187403 |
| 2026-04-2721:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-182391 |
| 2026-02-1922:14 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001576280-26-000013 |
| 2026-02-1921:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-26-000012 |
| 2026-01-1211:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001576280-26-000004 |
| 2025-11-0722:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-272592 |
| 2025-10-2921:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001576280-25-000277 |
| 2025-10-2920:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-25-000276 |
| 2025-09-2411:50 ET | 8-K | 7.01 Regulation FD disclosure | 0001576280-25-000269 |
| 2025-09-1520:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001576280-25-000267 |
| 2025-07-3021:13 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001576280-25-000246 |
| 2025-07-3020:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-25-000245 |
| 2025-06-2020:22 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-143681 |
| 2025-04-3021:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001576280-25-000136 |
| 2025-04-3020:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-25-000135 |
| 2025-04-2920:29 ET | DEF 14A | Proxy statementPeriod 2025-06-18 | 0001193125-25-103890 |
| 2025-04-0920:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-076885 |
| 2025-02-2022:17 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001576280-25-000044 |
| 2025-02-2021:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-25-000043 |
| 2025-02-1422:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-027362 |
| 2025-02-0711:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-022242 |
| 2025-01-1321:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005319 |
| 2024-11-0622:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001576280-24-000261 |
| 2024-11-0621:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-24-000260 |
| 2024-10-2421:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-242960 |
| 2024-08-2320:10 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-206179 |
| 2024-08-0721:12 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001576280-24-000190 |
| 2024-08-0720:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-24-000189 |
| 2024-07-2910:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-186674 |
| 2024-07-1821:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-181093 |
| 2024-06-1413:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-161223 |
| 2024-05-3120:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-151836 |
| 2024-05-2411:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-146510 |
| 2024-05-0920:59 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001576280-24-000109 |
| 2024-05-0920:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-24-000108 |
| 2024-04-2520:21 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001193125-24-113951 |
| 2024-03-2221:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-075436 |
| 2024-02-2222:23 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001576280-24-000043 |
| 2024-02-2221:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001576280-24-000039 |
| 2024-02-0121:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-021871 |
| 2024-01-0821:17 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-004446 |
| 2023-12-2121:07 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-301187 |
| 2023-12-1922:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-298718 |
| 2023-11-1511:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-277418 |
| 2023-11-0621:58 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001576280-23-000187 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.